Lithium carbonate - Generic Drug Details

What are the generic sources for lithium carbonate and what is the scope of freedom to operate?

Lithium carbonate is the generic ingredient in seven branded drugs marketed by Noven Therap, Able, Alembic Ltd, Apotex Inc, Glenmark Pharms Ltd, Hetero Labs Ltd Iii, Hikma, Norvium Bioscience, Usl Pharma, Watson Labs, Solvay, Jds Pharms, Alembic, Glenmark Pharms Inc, Heritage Pharma, Hikma Intl Pharms, Mylan Pharms Inc, Unique, Ani Pharms, Bayer Pharms, Pfizer, and Sun Pharm Inds Inc, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for lithium carbonate. Twenty-four suppliers are listed for this compound.

Summary for lithium carbonate

US Patents:	0
Tradenames:	7
Applicants:	22
NDAs:	36
Drug Master File Entries:	13
Finished Product Suppliers / Packagers:	24
Raw Ingredient (Bulk) Api Vendors:	133
Clinical Trials:	99
Patent Applications:	5,475
Drug Prices:	Drug price trends for lithium carbonate
What excipients (inactive ingredients) are in lithium carbonate?	lithium carbonate excipients list
DailyMed Link:	lithium carbonate at DailyMed

See drug prices for lithium carbonate

See drug sales revenues for lithium carbonate

Recent Clinical Trials for lithium carbonate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mental Health Services in the Capital Region, Denmark	Phase 4
Second Xiangya Hospital of Central South University	Phase 1/Phase 2
First Affiliated Hospital of Chongqing Medical University	Phase 1/Phase 2

See all lithium carbonate clinical trials

Pharmacology for lithium carbonate

Drug Class

Mood Stabilizer

Medical Subject Heading (MeSH) Categories for lithium carbonate

Antidepressive Agents

Antimanic Agents

Enzyme Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for lithium carbonate

N05AN	Lithium
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for lithium carbonate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hetero Labs Ltd Iii	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	090702-003	Sep 25, 2009	AB	RX	No	No
Hetero Labs Ltd Iii	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	090702-002	Sep 25, 2009	AB	RX	No	No
Able	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	076823-002	Jun 29, 2004		DISCN	No	No
Norvium Bioscience	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	078763-001	Apr 15, 2008		DISCN	No	No
Hetero Labs Ltd Iii	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	090702-001	Sep 25, 2009	AB	RX	No	No

Expired US Patents for lithium carbonate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ani Pharms	LITHOBID	lithium carbonate	TABLET, EXTENDED RELEASE;ORAL	018027-001	Approved Prior to Jan 1, 1982

Lithium carbonate Market Analysis and Financial Projection Experimental

Lithium Carbonate Market Dynamics and Financial Trajectory

Market Overview

The lithium carbonate market is poised for significant growth, driven by several key factors across various industries. Here’s a comprehensive look at the market dynamics and financial trajectory of lithium carbonate.

Market Size and Growth Projections

As of 2024, the lithium carbonate market is estimated to be around 0.56 thousand LCE (Lithium Carbonate Equivalent) kilotons and is expected to grow at a Compound Annual Growth Rate (CAGR) of 23.22% to reach 0.16 thousand LCE kilotons by 2029[1][3].

Key Drivers of Growth

Increasing Demand for Lithium-Ion Batteries

The surge in demand for lithium-ion batteries, particularly in the electric vehicle (EV) sector, is a major driver of the lithium carbonate market. As governments implement stricter pollution regulations and offer incentives for EV adoption, the demand for lithium-ion batteries is expected to rise, thereby increasing the demand for lithium carbonate[5].

Pharmaceutical Applications

Lithium carbonate is a critical component in the production of pharmaceutical formulations, especially for treating mood disorders such as bipolar disorder and depression. The growing awareness of mental health issues, an aging population, and ongoing research in neuroscience are driving the demand for pharmaceutical-grade lithium carbonate. This segment is anticipated to grow at a CAGR of 3.31% from 2023 to 2028[4].

Glass and Ceramics Industry

The glass and ceramics industries also contribute significantly to the demand for lithium carbonate. The material is used to improve the strength and durability of glass and ceramics, and investments in these sectors are expected to boost the market[1].

Regional Market Dynamics

Asia-Pacific Dominance

The Asia-Pacific region is expected to dominate the lithium carbonate market, driven by the rising demand from Li-ion batteries, pharmaceuticals, and the glass and ceramics industries. Countries like China, Japan, and South Korea are key players in this region, with Japan's market projected to grow at an 11.3% CAGR through 2034[1][5].

Financial Trajectory

Revenue Projections

The global lithium carbonate market is forecasted to reach a worth of US$ 9.69 billion in 2024 and is expected to rise at a CAGR of 11.1% to reach US$ 27.75 billion by 2034. The pharmaceutical segment alone is projected to reach US$ 13.57 billion by 2034[5].

Price Trends

Lithium carbonate prices have experienced significant fluctuations. In China, prices plummeted from an all-time high of $81,360 per tonne in November 2022 to $20,782 per tonne in recent times, representing a 67% year-on-year decline. This drop has led Chinese refining companies to cut production or suspend operations[2].

Impact of Government Policies

Government policies and potential nationalization of key players, such as SQM in Chile, introduce uncertainties and risks associated with state control of lithium. These factors can impact the profitability and valuation of companies involved in the lithium carbonate market[2].

Challenges and Constraints

Extraction and Geographical Restrictions

Constraints in lithium extraction and geographical restrictions of lithium mines are expected to hinder the growth of the market. The limited availability of lithium resources and the complexities involved in extracting them pose significant challenges[1].

Market Volatility

The lithium carbonate market is subject to volatility due to factors such as changes in demand, supply chain disruptions, and geopolitical issues. The recent decline in lithium prices and the subsequent impact on refining companies highlight the market's sensitivity to external factors[2].

Key Players and Innovation

Leading players in the lithium carbonate market, including Ganfeng Lithium Co., Ltd., Orocobre Limited, SQM S.A., Tianqi Lithium Corporation, Albemarle Corp., and Livent Corp., are driving innovation and expansion in the sector. These companies are investing in research and development to improve extraction methods, battery technology, and pharmaceutical applications[5].

Market Segmentation

The lithium carbonate market is segmented based on purity, grade, and application. The purity segments include 98.5% to 99.4%, 99.5% to 99.8%, and 99.9%. The grade segments include high purity, battery, and pharmaceutical. Applications span li-ion batteries, glass & ceramics, cement manufacturing, aluminum production, and pharmaceuticals[5].

Conclusion

The lithium carbonate market is on a robust growth trajectory, driven by increasing demand from the EV sector, pharmaceutical applications, and the glass and ceramics industries. Despite challenges related to extraction and market volatility, the market is expected to expand significantly over the next decade.

Key Takeaways

• Market Growth: The lithium carbonate market is projected to grow at a CAGR of 23.22% from 2024 to 2029.
• Regional Dominance: The Asia-Pacific region is expected to dominate the market.
• Pharmaceutical Applications: Growing awareness of mental health issues and an aging population drive the demand for pharmaceutical-grade lithium carbonate.
• Financial Projections: The global market is forecasted to reach US$ 27.75 billion by 2034.
• Challenges: Constraints in lithium extraction and geographical restrictions pose significant challenges.

FAQs

Q: What is the expected CAGR of the lithium carbonate market from 2024 to 2029?

A: The lithium carbonate market is expected to grow at a CAGR of 23.22% from 2024 to 2029[1].

Q: Which region is expected to dominate the lithium carbonate market?

A: The Asia-Pacific region is expected to dominate the lithium carbonate market[1].

Q: What are the primary drivers of the pharmaceutical-grade lithium carbonate market?

A: The primary drivers include rising mental health awareness, an aging population, and ongoing research in neuroscience[4].

Q: How has the price of lithium carbonate changed recently?

A: The price of lithium carbonate in China has plummeted from $81,360 per tonne in November 2022 to $20,782 per tonne in recent times, a 67% year-on-year decline[2].

Q: What is the projected worth of the global lithium carbonate market by 2034?

A: The global lithium carbonate market is forecasted to reach US$ 27.75 billion by 2034[5].

Sources

1. Mordor Intelligence: Lithium Carbonate Market Size & Share Analysis
2. CarbonCredits.com: Top Lithium Stocks Making Waves in 2024
3. Mordor Intelligence: Lithium Carbonate Market Size & Share Analysis (Market Summary)
4. TechSci Research: Pharmaceutical Grade Lithium Carbonate Market
5. GlobeNewswire: Lithium Carbonate Market is Projected Reach US$ 27.75 Billion at 11.1% CAGR By 2034 - Fact.MR Report